Filing Details

Accession Number:
0001140361-19-020486
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2019-11-13 20:31:08
Reporting Period:
2019-11-08
Accepted Time:
2019-11-13 20:31:08
Original Submission Date:
2019-11-12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1434418 Constellation Pharmaceuticals Inc CNST () CA
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
315054 California Of University The Of Regents 1111 Broadway, Suite 2100
Oakland CA 94607
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-11-08 100,000 $30.25 2,197,406 No 4 S Direct
Common Stock Disposition 2019-11-08 74,316 $30.44 2,123,090 No 4 S Direct
Common Stock Disposition 2019-11-12 12,800 $32.77 2,110,290 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. Share amount amended from 100,0000 to 100,000, and Securities Acquired (A) amended to Securities Disposed of (D).
  2. Securities Acquired (A) amended to Securities Disposed of (D), and Amount of Securities Beneficially Owned Following Reported Transaction(s) amended from 2,127,090 to 2,123,090.
  3. Securities Acquired (A) amended to Securities Disposed of (D), and Amount of Securities Beneficially Owned Following Reported Transaction(s) amended from 2,111,290 to 2,110,290.